Amit Kumar, Chief Executive Officer at Anixa Biosciences Inc (ANIX), bought 5,000 shares at $3.46 ($17K) on 2026-07-20, disclosed to the SEC on 2026-07-21.
CEO Amit Kumar purchased 5,000 shares for $17,300, marking the largest purchase of his career, signaling confidence in the company's oncology pipeline. This trade coincides with a 30-day price surge of 18.9% and the company's progress on a breast cancer vaccine and CAR-T therapies.
The stock has surged 18.9% over the last 30 days and is currently trading 36.59% below its 52-week high of $5.4566.
Nothing distinguishes this filing.
| Filing → |
| ANIX | BUY | 2026-09-11 | $14K | — | Filing → |
| ANIX | BUY | 2026-08-03 | $17K | — | Filing → |
| ANIX | BUY | 2026-07-28 | $17K | — | Filing → |